We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




Total Plasma Homocysteine Methods Evaluated

By LabMedica International staff writers
Posted on 15 Aug 2022

Homocysteine (HCY) is occasionally requested as a prognostic risk factor in patients with cardiovascular diseases. More...

Homocysteine is an intermediary amino acid formed in methionine metabolism, with elevated total homocysteine (tHCY) is a biomarker of cardiovascular and cerebrovascular diseases.

Hyperhomocysteinaemia has been implicated in the development of stroke, exerting neurotoxic effects on neuronal cells by acting as an agonist for glutamate receptors, metabotropic receptors and ionotropic receptors so that overstimulation of these receptors increases levels of cytoplasmic calcium, free radicals and caspases.

Clinical Biochemists at the University College Dublin (Dublin, Republic of Ireland) and their colleagues obtained plasma samples of 91 patients and the decision to undertake homocysteine analysis was made by physicians who identified diagnostic and/or monitoring benefits from homocysteine analysis for their patients. The study cohort was 49.5% male with a mean age of 49.66 ± 15.72 years. The objectives were to evaluate the Abbott ARCHITECT immunoassay and compare it with the JEOL method and to investigate if the clinical utility of the biomarker was comparable with both methods in patients with cardiovascular disease and cerebrovascular disease.

The Abbott ARCHITECT homocysteine assay (ARCHITECT i2000SR analyzer, Abbott Park, IL, USA), is a one-step immunoassay which utilizes chemiluminescent microparticle immunoassay (CMIA). The ion exchange chromatography (IEC) method used the AminoTac JLC500/V analyzer (JEOL, Akishima, Tokyo, Japan). The analyzer measures HCY with photometric detection after a reaction with ninhydrin. The accuracy was verified using nine external quality assessment (EQA) specimens and the linearity was assessed in accordance with the guideline provided by the Clinical and Laboratory Standards Institute.

The investigators reported that for the Abbott immunoassay, accuracy was assessed, with UK NEQAS EQA specimens, by the correlation of the Abbott immunoassay measurements to the Abbott ARCHITECT immunoassay mean (bias = 1.6%), and to the overall immunoassay mean (bias = 2.0%). The total imprecision was 2.7% (11.0 μmol/L), 2.4% (16.80 μmol/L) and 2.8% (24.3 μmol/L) respectively. Taking reference ranges into consideration, 66 (72.5%) patients were within the reference ranges of both methods, while 12 patients (13.2%) patients were above in both methods, including the two patients diagnosed with homocystinuria. Other patients with tHCY values above reference ranges of both methods were diagnosed with ischemic stroke, transient ischemic attack (TIA), peripheral neuropathy (secondary to vitamin B12 deficiency), unspecific hemiplegia, tricuspid atresia, major depressive disorder and borderline personality disorder.

The authors concluded that the immunoassay demonstrated robust performance in its verification and showed good comparability with the IEC, but with some biases so caution is needed if both are used interchangeably. The immunoassay offers an automated alternative to IEC in the assessment of hyperhomocysteinaemia. The study was published on August 11, 2022 in the journal Practical Laboratory Medicine.

Related Links:
University College Dublin 
Abbott 
JEOL 


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
New
8-Channel Pipette
SAPPHIRE 20–300 µL
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.